Effect of interleukin 12 gene therapy on microvessel density and microenvironment in a rabbit model of vx2 liver cancer

Xiang Wen Xia, Xin Li, Yi Ming Liu, Bin Liang, Chuan Sheng Zheng, Gan Sheng Feng, Hui Min Liang

Research output: Contribution to journalArticle

Abstract

AIM: To evaluate the effect of interleukin-12 (IL-12) gene ther apyon microvessel density and microenvironment in a postchemoembolization VX2 liver cancer model, and to investigate its anti-tumor mechanism. METHODS: Rabbits with VX2 hepatic tumors were randomized into 4 groups, with eight rabbits in each group. Interventional procedure protocols were performed as follows: 0.9% saline solution (group 1, control), transcatheter arterial chemoembolization alone (group 2, lipiodol + mitomycin), intra-arterial IL-12 gene infusion (group 3, IL-12 gene therapy alone), and intraarterial IL-12 gene infusion in combination with chemoembolization (group 4, IL-12 plus chemoembolization). Fourteen days after therapy, tumor tissues of the sacrificed animals were explanted for immunohistochemistry to evaluate microvessel density, effector T cells (CD3+, CD4+, and CD8+) and regulatory T cells (FoxP3+). RESULTS: The microvessel density and FoxP3+ T cells in group 2 were significantly higher than those in group 1, but the differences in CD3+, CD4+, and CD8+ T cells between the two groups were not significant. The microvessel density in gene therapy groups (groups 3 and 4) were significantly lower, and CD3+, CD4+, and CD8+ T cells in these two groups were significantly higher than those in groups 1 and 2. The differences in CD3+, CD4+, and CD8+ T cells between the two gene therapy groups (groups 3 and 4) were not significant. The difference in FoxP3+ T cells was not significant between before and after IL-12 gene therapy. The differences in the level of FoxP3 were not significant between groups 3 and 1, as well as between groups 4 and 2. CONCLUSION: IL-12 gene therapy can inhibit angiogenesis and induce effector T cell (CD3+, CD4+, and CD8+) infiltration in the VX2 liver cancer model, but the efficacy appears to be limited by the regulatory T cells (FoxP3+) existing in the tumors and overexpressed after chemoembolization.

Original languageEnglish (US)
Pages (from-to)97-103
Number of pages7
JournalWorld Chinese Journal of Digestology
Volume24
Issue number1
DOIs
StatePublished - Jan 8 2016
Externally publishedYes

Fingerprint

Interleukin-12
Liver Neoplasms
Microvessels
Genetic Therapy
Rabbits
T-Lymphocytes
Regulatory T-Lymphocytes
Neoplasms
Genes
Ethiodized Oil
Mitomycin
Cell- and Tissue-Based Therapy
Sodium Chloride
Immunohistochemistry
Control Groups
Liver

Keywords

  • Angiogenesis
  • Chemoembolization
  • Gene therapy
  • Interleukin 12
  • Microenvironment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Effect of interleukin 12 gene therapy on microvessel density and microenvironment in a rabbit model of vx2 liver cancer. / Xia, Xiang Wen; Li, Xin; Liu, Yi Ming; Liang, Bin; Zheng, Chuan Sheng; Feng, Gan Sheng; Liang, Hui Min.

In: World Chinese Journal of Digestology, Vol. 24, No. 1, 08.01.2016, p. 97-103.

Research output: Contribution to journalArticle

Xia, Xiang Wen ; Li, Xin ; Liu, Yi Ming ; Liang, Bin ; Zheng, Chuan Sheng ; Feng, Gan Sheng ; Liang, Hui Min. / Effect of interleukin 12 gene therapy on microvessel density and microenvironment in a rabbit model of vx2 liver cancer. In: World Chinese Journal of Digestology. 2016 ; Vol. 24, No. 1. pp. 97-103.
@article{46961d1739f24e80a069e48b61ebfa20,
title = "Effect of interleukin 12 gene therapy on microvessel density and microenvironment in a rabbit model of vx2 liver cancer",
abstract = "AIM: To evaluate the effect of interleukin-12 (IL-12) gene ther apyon microvessel density and microenvironment in a postchemoembolization VX2 liver cancer model, and to investigate its anti-tumor mechanism. METHODS: Rabbits with VX2 hepatic tumors were randomized into 4 groups, with eight rabbits in each group. Interventional procedure protocols were performed as follows: 0.9{\%} saline solution (group 1, control), transcatheter arterial chemoembolization alone (group 2, lipiodol + mitomycin), intra-arterial IL-12 gene infusion (group 3, IL-12 gene therapy alone), and intraarterial IL-12 gene infusion in combination with chemoembolization (group 4, IL-12 plus chemoembolization). Fourteen days after therapy, tumor tissues of the sacrificed animals were explanted for immunohistochemistry to evaluate microvessel density, effector T cells (CD3+, CD4+, and CD8+) and regulatory T cells (FoxP3+). RESULTS: The microvessel density and FoxP3+ T cells in group 2 were significantly higher than those in group 1, but the differences in CD3+, CD4+, and CD8+ T cells between the two groups were not significant. The microvessel density in gene therapy groups (groups 3 and 4) were significantly lower, and CD3+, CD4+, and CD8+ T cells in these two groups were significantly higher than those in groups 1 and 2. The differences in CD3+, CD4+, and CD8+ T cells between the two gene therapy groups (groups 3 and 4) were not significant. The difference in FoxP3+ T cells was not significant between before and after IL-12 gene therapy. The differences in the level of FoxP3 were not significant between groups 3 and 1, as well as between groups 4 and 2. CONCLUSION: IL-12 gene therapy can inhibit angiogenesis and induce effector T cell (CD3+, CD4+, and CD8+) infiltration in the VX2 liver cancer model, but the efficacy appears to be limited by the regulatory T cells (FoxP3+) existing in the tumors and overexpressed after chemoembolization.",
keywords = "Angiogenesis, Chemoembolization, Gene therapy, Interleukin 12, Microenvironment",
author = "Xia, {Xiang Wen} and Xin Li and Liu, {Yi Ming} and Bin Liang and Zheng, {Chuan Sheng} and Feng, {Gan Sheng} and Liang, {Hui Min}",
year = "2016",
month = "1",
day = "8",
doi = "10.11569/wcjd.v24.i1.97",
language = "English (US)",
volume = "24",
pages = "97--103",
journal = "World Chinese Journal of Digestology",
issn = "1009-3079",
publisher = "WJC Press",
number = "1",

}

TY - JOUR

T1 - Effect of interleukin 12 gene therapy on microvessel density and microenvironment in a rabbit model of vx2 liver cancer

AU - Xia, Xiang Wen

AU - Li, Xin

AU - Liu, Yi Ming

AU - Liang, Bin

AU - Zheng, Chuan Sheng

AU - Feng, Gan Sheng

AU - Liang, Hui Min

PY - 2016/1/8

Y1 - 2016/1/8

N2 - AIM: To evaluate the effect of interleukin-12 (IL-12) gene ther apyon microvessel density and microenvironment in a postchemoembolization VX2 liver cancer model, and to investigate its anti-tumor mechanism. METHODS: Rabbits with VX2 hepatic tumors were randomized into 4 groups, with eight rabbits in each group. Interventional procedure protocols were performed as follows: 0.9% saline solution (group 1, control), transcatheter arterial chemoembolization alone (group 2, lipiodol + mitomycin), intra-arterial IL-12 gene infusion (group 3, IL-12 gene therapy alone), and intraarterial IL-12 gene infusion in combination with chemoembolization (group 4, IL-12 plus chemoembolization). Fourteen days after therapy, tumor tissues of the sacrificed animals were explanted for immunohistochemistry to evaluate microvessel density, effector T cells (CD3+, CD4+, and CD8+) and regulatory T cells (FoxP3+). RESULTS: The microvessel density and FoxP3+ T cells in group 2 were significantly higher than those in group 1, but the differences in CD3+, CD4+, and CD8+ T cells between the two groups were not significant. The microvessel density in gene therapy groups (groups 3 and 4) were significantly lower, and CD3+, CD4+, and CD8+ T cells in these two groups were significantly higher than those in groups 1 and 2. The differences in CD3+, CD4+, and CD8+ T cells between the two gene therapy groups (groups 3 and 4) were not significant. The difference in FoxP3+ T cells was not significant between before and after IL-12 gene therapy. The differences in the level of FoxP3 were not significant between groups 3 and 1, as well as between groups 4 and 2. CONCLUSION: IL-12 gene therapy can inhibit angiogenesis and induce effector T cell (CD3+, CD4+, and CD8+) infiltration in the VX2 liver cancer model, but the efficacy appears to be limited by the regulatory T cells (FoxP3+) existing in the tumors and overexpressed after chemoembolization.

AB - AIM: To evaluate the effect of interleukin-12 (IL-12) gene ther apyon microvessel density and microenvironment in a postchemoembolization VX2 liver cancer model, and to investigate its anti-tumor mechanism. METHODS: Rabbits with VX2 hepatic tumors were randomized into 4 groups, with eight rabbits in each group. Interventional procedure protocols were performed as follows: 0.9% saline solution (group 1, control), transcatheter arterial chemoembolization alone (group 2, lipiodol + mitomycin), intra-arterial IL-12 gene infusion (group 3, IL-12 gene therapy alone), and intraarterial IL-12 gene infusion in combination with chemoembolization (group 4, IL-12 plus chemoembolization). Fourteen days after therapy, tumor tissues of the sacrificed animals were explanted for immunohistochemistry to evaluate microvessel density, effector T cells (CD3+, CD4+, and CD8+) and regulatory T cells (FoxP3+). RESULTS: The microvessel density and FoxP3+ T cells in group 2 were significantly higher than those in group 1, but the differences in CD3+, CD4+, and CD8+ T cells between the two groups were not significant. The microvessel density in gene therapy groups (groups 3 and 4) were significantly lower, and CD3+, CD4+, and CD8+ T cells in these two groups were significantly higher than those in groups 1 and 2. The differences in CD3+, CD4+, and CD8+ T cells between the two gene therapy groups (groups 3 and 4) were not significant. The difference in FoxP3+ T cells was not significant between before and after IL-12 gene therapy. The differences in the level of FoxP3 were not significant between groups 3 and 1, as well as between groups 4 and 2. CONCLUSION: IL-12 gene therapy can inhibit angiogenesis and induce effector T cell (CD3+, CD4+, and CD8+) infiltration in the VX2 liver cancer model, but the efficacy appears to be limited by the regulatory T cells (FoxP3+) existing in the tumors and overexpressed after chemoembolization.

KW - Angiogenesis

KW - Chemoembolization

KW - Gene therapy

KW - Interleukin 12

KW - Microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84953790793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953790793&partnerID=8YFLogxK

U2 - 10.11569/wcjd.v24.i1.97

DO - 10.11569/wcjd.v24.i1.97

M3 - Article

AN - SCOPUS:84953790793

VL - 24

SP - 97

EP - 103

JO - World Chinese Journal of Digestology

JF - World Chinese Journal of Digestology

SN - 1009-3079

IS - 1

ER -